Oncodynamix Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 18-12-2024
- Paid Up Capital ₹ 8.32 M
as on 18-12-2024
- Company Age 4 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2022)
- Profit -198.83%
(FY 2022)
- Ebitda -210.76%
(FY 2022)
- Net Worth -22.27%
(FY 2022)
- Total Assets 237.82%
(FY 2022)
About Oncodynamix Lifesciences
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 8.32 M, as per Ministry of Corporate Affairs (MCA) records.
Janardhanrao Babu and Dipanjan Chakraborty serve as directors at the Company.
- CIN/LLPIN
U73200KA2020PTC137226
- Company No.
137226
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Aug 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Oncodynamix Lifesciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dipanjan Chakraborty  | Additional Director | Current | |
| Janardhanrao Babu | Director | 13-Aug-2020 | Current |
Financial Performance of Oncodynamix Lifesciences.
Oncodynamix Lifesciences Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 198.83% decrease in profit. The company's net worth observed a substantial decline by a decrease of 22.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Oncodynamix Lifesciences?
In 2022, Oncodynamix Lifesciences had a promoter holding of 93.30% and a public holding of 6.70%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Oncodynamix Lifesciences?
Oncodynamix Lifesciences has a workforce of 0 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Oncodynamix Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oncodynamix Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
